In our case, IHC analysis for LS-related tumors was informative and identified loss of MSH2 and MSH6 expression in the ACC and endometrial tumors analyzed from affected patients with the germline MSH2 mutation. This evidence concerns the gene MSH6 and endometrium neoplasm.